Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL669679 | 0.97 | TSHR (0.48) | TSHR | |
| Hydrochloric Acid SCHEMBL27874469 | 0.94 | TSHR (0.46) | TSHR | |
| Water SCHEMBL141741 | 0.94 | TSHR (0.46) | TSHR | |
| SCHEMBL6847292 | 0.90 | TSHR (0.42) | TSHR | |
| Formic Acid SCHEMBL3678404 | 0.85 | TSHR (0.39) | TSHR | |
| Acetic Acid SCHEMBL27811256 | 0.85 | TSHR (0.39) | TSHR | |
| Silicate SCHEMBL6847289 | 0.85 | TSHR (0.39) | TSHR | |
| SCHEMBL11880292 | 0.84 | TSHR (0.42) | TSHR | |
| SCHEMBL2337550 | 0.78 | TSHR (0.33) | TSHR | |
| SCHEMBL15204261 | 0.78 | TSHR (0.46) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1776125-A2 | FUNCTIONALIZED SINGLE WALLED CARBON NANOTUBES | HYPERION CATALYSIS INTERNATIONAL, INC. (US) | 2007-04-25 | — | — | EP | disclosed |
| WO-2006130150-A2 | FUNCTIONALIZED SINGLE WALLED CARBON NANOTUBES | HYPERION CATALYSIS INTERNATIONAL, INC. (US) | 2006-12-07 | — | — | WO | disclosed |
| EP-0910340-A4 | FUNCTIONALIZED NANOTUBES | HYPERION CATALYSIS INT (US) | 2004-11-17 | — | — | EP | disclosed |
| US-20040202603-A1 | graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils | HYPERION CATALYSIS INTERNATIONAL, INC. | 2004-10-14 | — | — | US | disclosed |
| CN-1217653-A | Functionalized nanotubes | HYPERION CATALYSIS INT (US) | 1999-05-26 | — | — | CN | disclosed |
| EP-0910340-A1 | FUNCTIONALIZED NANOTUBES | HYPERION CATALYSIS INTERNATIONAL, INC. (US) | 1999-04-28 | — | — | EP | disclosed |
| WO-1997032571-A1 | FUNCTIONALIZED NANOTUBES | HYPERION CATALYSIS INTERNATIONAL, INC. (US) | 1997-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040202603-A1 | graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils | FSCN1, CYCS, TUBA3C | TSHR 4354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.